RTI Surgical’s integration of Paradigm progressed slower than expected in 3Q19, leading to softer sales of coflex and a 2019 revenue guidance reduction.
Conformis’ 3Q19 sales declined in the mid-single digits due to continuing coverage denials from Aetna. An updated policy ruling is expected by year-end.
NuVasive’s 3Q19 growth was driven by sales of U.S. spinal hardware as the company continues to evangelize adoption of minimally invasive spinal surgery.
Alphatec continued its run of double-digit growth in 3Q19 on the strength of an aggressive new product launch schedule and a revitalized sales channel.